Physician profile
Edward Damore
NPI 1144244682
$964.77
in general payments reported to CMS, 2019-2025
12 companies · $84.99 in 2025
The $84.99 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $75.14 · 2022: $316 · 2023: $164 · 2024: $26.72 · 2025: $84.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $275.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $208.69 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $206.09 | 2019-2025 | Exparel, Iovera, Zilretta |
| Biotissue Holdings INC. | $171.10 | 2022 | |
| Axogen | $81.32 | 2022 | |
| Fidia Pharma USA INC. | $66.80 | 2022-2023 | Hymovis, Triluron |
| Smith+Nephew, INC. | $49.60 | 2023 | Grafix Pl, Pico |
| Vertex Pharmaceuticals Incorporated | $48.05 | 2024-2025 | |
| Orthofix Medical, INC. | $40.97 | 2022-2023 | Physio-Stim |
| Spr Therapeutics, INC | $29.88 | 2023 | Sprint Pns System |
| Baudax Bio INC. | $25.03 | 2020 | |
| Boston Scientific Corporation | $21.07 | 2025 | Wavewriter Alpha Prime 16 |
| Trevena, INC. | $16.17 | 2023 | Olinvyk |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Damore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.